LENZ Therapeutics, Inc. (LENZ) vs Tonix Pharmaceuticals Holding Corp. (TNXP)
A side-by-side comparison of LENZ Therapeutics, Inc. and Tonix Pharmaceuticals Holding Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LENZ
LENZ Therapeutics, Inc.
$3.79HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TNXP
Tonix Pharmaceuticals Holding Corp.
$7.70HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — LENZ vs TNXP
growth of $100 · dividends reinvested · last 5yLENZ -91.4% (-38.7%/yr)TNXP -100.0% (-89.1%/yr)LENZ compounded faster over this window
Log scale — wide-divergence pair
LENZ TNXP
LENZ vs TNXP: by the numbers
- •TNXP is the larger company ($123M vs $119M market cap).
- •Both run net losses; TNXP's is the smaller (-548.64% vs -586.74% net margin).
Metrics side by side
Valuation
| Metric | LENZ | TNXP |
|---|---|---|
| P/S ratio | 5.53 | 4.21 |
| P/B ratio | 0.54 | 0.55 |
Profitability
| Metric | LENZ | TNXP |
|---|---|---|
| Gross margin | 90.14% | 34.65% |
| Operating margin | -477.46% | -959.05% |
| Net margin | -586.74% | -548.64% |
| ROE | -57.47% | -71.83% |
| ROIC | -61.84% | -74.08% |
Growth (annualized)
| Metric | LENZ | TNXP |
|---|---|---|
| Total return CAGR (5Y) | -35.49% | -87.55% |
Frequently asked
- How have LENZ and TNXP total returns compared?
- Over the past 5 years, LENZ delivered -35.49% and TNXP delivered -87.55% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.